Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 61, Issue 1, Pages 1-9
Publisher
Springer Nature
Online
2011-11-04
DOI
10.1007/s00011-011-0393-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Langendorff Heart: A Model System To Study Cardiovascular Effects of Engineered Nanoparticles
- (2011) Andreas Stampfl et al. ACS Nano
- Advances in the field of nanooncology
- (2011) KK Jain BMC Medicine
- Delivery of nanoparticle-complexed drugs across the vascular endothelial barrier via caveolae
- (2011) Zhenjia Wang et al. IUBMB LIFE
- Nanonization of Itraconazole by High Pressure Homogenization: Stabilizer Optimization and Effect of Particle Size on Oral Absorption
- (2011) Wei Sun et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Overcoming in vivo barriers to targeted nanodelivery
- (2011) Adrian Chrastina et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Aptamer-Based Tumor-Targeted Drug Delivery for Photodynamic Therapy
- (2010) Yen-An Shieh et al. ACS Nano
- A proof-of-concept study to evaluate the anti-inflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma
- (2010) Peter A. Williamson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Characterization of Respiratory Drug Delivery with Enhanced Condensational Growth using an Individual Path Model of the Entire Tracheobronchial Airways
- (2010) Geng Tian et al. ANNALS OF BIOMEDICAL ENGINEERING
- Water-soluble fullerene (c60) inhibits the development of arthritis in the rat model of arthritis
- (2010) Kazuo Yudoh International Journal of Nanomedicine
- Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis
- (2010) Otilia May Yue Koo et al. PHARMACEUTICAL RESEARCH
- The prevalence of asthma and COPD in Italy: A practice-based study
- (2010) Mario Cazzola et al. RESPIRATORY MEDICINE
- The New Toxicology of Sophisticated Materials: Nanotoxicology and Beyond
- (2010) A. D. Maynard et al. TOXICOLOGICAL SCIENCES
- Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation
- (2009) Wassana Wijagkanalan et al. JOURNAL OF CONTROLLED RELEASE
- Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
- (2009) Andrea Rubbert-Roth et al. ARTHRITIS RESEARCH & THERAPY
- Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer
- (2008) Ching-Li Tseng et al. BIOMATERIALS
- Nano-salbutamol dry powder inhalation: A new approach for treating broncho-constrictive conditions
- (2008) Bhavna et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma
- (2008) S SHREWSBURY et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
- (2008) Zhi-Hua Chen et al. PLoS One
- Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
- (2008) Elaine M. Merisko-Liversidge et al. TOXICOLOGIC PATHOLOGY
- Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions
- (2007) Lei Gao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started